Do biomarkers of COVID-19 severity simply reflect a stress response in type 2 diabetes: Biomarker response to hypoglycemia

Metabolism. 2021 Jan:114:154417. doi: 10.1016/j.metabol.2020.154417. Epub 2020 Nov 4.

¹ Diabetes Research Center (DRC), Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), PO Box 34110, Doha, Qatar. Electronic address: amoin@hbku.edu.qa.
² Academic Endocrinology, Diabetes and Metabolism, Hull York Medical School, Hull, UK; Leeds Medical School, Leeds, UK.
³ Academic Endocrinology, Diabetes and Metabolism, Hull York Medical School, Hull, UK. Electronic address: Thozhukat.Sathyapalan@hyms.ac.uk.
⁴ Royal College of Surgeons in Ireland Bahrain, Adliya, Bahrain. Electronic address: satkin@rcsi.com.
⁵ Diabetes Research Center (DRC), Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), PO Box 34110, Doha, Qatar. Electronic address: abutler@hbku.edu.qa.

No abstract available

Keywords: COVID-19; Cytokine; Hypoglycemia; SARS-CoV-2; Type 2 diabetes.

Publication types